Name | NGI-1 |
---|---|
Synonyms |
MFCD06358908
5-(Dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(1-pyrrolidinyl)benzamide Benzamide, 5-[(dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)- |
Description | NGI-1 is a cell permeable inhibitor. |
---|---|
Related Catalog | |
In Vitro | NGI-1 blocks EGFR N-linked glycosylation in lung adenocarcinoma cells as assessed. In controls EGFR is biotinylated, consistent with its plasma membrane expression, but in NGI-1 treated cells the EGFR is predominantly found in the non-biotinylated intracellular fraction suggesting a change in cellular localization[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C17H22N4O3S2 |
Molecular Weight | 394.512 |
Exact Mass | 394.113342 |
LogP | 2.75 |
Index of Refraction | 1.634 |
Storage condition | -20℃ |